Table II.
Summary of types of alopecia associated with COVID-19 in 1826 patients and survival data
| Characteristics | AA | AE | AGA | PA | TE | Unclassified |
|---|---|---|---|---|---|---|
| Number of patients (n = 1826) | 143 (7.8%) | 2 (0.1%) | 561 (30.7%) | 2 (0.1%) | 362 (19.8%) | 756 (41.4%) |
| Mean age (y), number of patients with reported age, age range | 36.1 (n = 10) | 29.5 (n = 2) | 61.1 (n = 484) | 43.0 (n = 2) | 48.0 (n = 352) | 51.5 (n = 206) |
| Range: 7-64 | Range: 24-35 | Range: 18-100 | Range: 37-49 | Range: 15-88 | Range: NR | |
| Sex | 4 M, 6 F 133 NR |
0 M, 2 F | 504 M, 57 F | 2 M, 0 F | 68 M, 284 F 10 NR |
29 M, 161 F 566 NR |
| Country of patient | Italy Netherlands Turkey United States |
Brazil Iraq |
Brazil Iran Peru Spain Switzerland United Kingdom |
Brazil United States |
Brazil China Iraq Italy Pakistan Poland Spain Switzerland Turkey United States |
Brazil China Iran Japan Mexico Thailand United Kingdom |
| Survival | 10/10 (100%) 133 NR |
2/2 (100%) 0 NR |
38/48 (79.2%) 513 NR |
Unknown 2 NR |
171/171 (100%) 191 NR |
193/193 (100%) 563 NR |
AA, Alopecia areata; AE, anagen effluvium; AGA, androgenic alopecia; F, female; M, male; NR, not reported; PA, pressure-induced alopecia; TE, telogen effluvium.